Floatz logo

Therapeutic Asset Ratings

6,305 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
trx319
Primary Progressive Multiple Sclerosis
Tr1X, Inc.P1/2CC (47)
tst003
Metastatic Neoplasm
Suzhou Transcenta Therapeutics Co., Ltd.P1/2CC (47)
tt-10
Castration-Resistant Prostate Carcinoma
Portage BiotechP1/2CC (47)
tt-10
Renal Cell Carcinoma
Portage BiotechP1/2CC (47)
tt-4
Castration-Resistant Prostate Carcinoma
Portage BiotechP1/2CC (47)
tt-4
Renal Cell Carcinoma
Portage BiotechP1/2CC (47)
tt-816
Neoplasm
Teon Therapeutics, Inc.P1/2CC (47)
Tyk-00540
Hormone Receptor-Positive Breast Cancer
TYK Medicines, IncP1/2CC (47)
Tyk-00540
Prostate Cancer
TYK Medicines, IncP1/2CC (47)
ucb4594
Esophageal Cancer
Cancer Research UKP1/2CC (47)
ucb4594
Triple-Negative Breast Carcinoma
Cancer Research UKP1/2CC (47)
Umbilical Cord Mesenchymal Stem Cell
Obesity Disorder
Nguyen Ton Ngoc HuynhP1/2CC (47)
Universal Donor Expanded Tgf-Beta-Imprinted Nk Cells
Her2-Receptor Negative Breast Cancer
Margaret Gatti-MaysP1/2CC (47)
Uromitexan
Metastatic Prostate Carcinoma
CuraCell TX ABP1/2CC (47)
Varenicline
Trigeminal Neuralgia
Kriya Therapeutics, Inc.P1/2CC (47)
vb15010
Prostate Cancer
Zhejiang Yangli Pharmaceutical Technology Co., Ltd.P1/2CC (47)
Vgn-R08B
Parkinson Disease
Shanghai Vitalgen BioPharma Co., Ltd.P1/2CC (47)
Vibostolimab
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP1/2CC (47)
(+)-Vincristine
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CC (47)
(+)-Vincristine
Liposarcoma
Milton S. Hershey Medical CenterP1/2CC (47)
Vls-1488
Ovarian Serous Adenocarcinoma
Volastra Therapeutics, Inc.P1/2CC (47)
Vmd-102
Non-Small Cell Lung Carcinoma
VM Discovery, Inc.P1/2CC (47)
Vofatamab
Urinary Bladder Carcinoma
Fusion Pharmaceuticals Inc.P1/2CC (47)
Vorinostat
Hematologic Disorder
University of Michigan Rogel Cancer CenterP1/2CC (47)
Wve-007
Obesity Disorder
Wave Life Sciences USA, Inc.P1/2CC (47)
Showing 2701 to 2725 of 6,305 assets
PreviousPage 109 of 253Next